Search

Read past stories about the extraordinary work being done and the passionate people behind it.

The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies.

Dr. Joseph Takahashi, noted for discovering the first gene controlling biological clocks in mammals, addressed the topic at the Society for Neuroscience annual meeting where he was awarded the Gruber Neuroscience Prize for his pioneering work in circadian rhythms.

UT Southwestern researchers have developed a software tool that uses artificial intelligence to recognize cancer cells from digital pathology images – giving clinicians a powerful way of predicting patient outcomes.

Investigators report an innovative strategy for treating advanced kidney cancer.

A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes that promote viral replication provides hope for new COVID-19 treatments.

David Sanders, Ph.D., Assistant Professor in the Center for Alzheimer’s and Neurodegenerative Diseases and Molecular Biology at UT Southwestern Medical Center, has been awarded $2.4 million over five years from the National Institutes of Health (NIH) to support his research into the role of RNA

Activating specific neurons in a part of the brain that serves as the body’s master circadian pacemaker caused mice to eat significantly more during a time of day when they would normally be at rest, a UT Southwestern Medical Center study shows.

Yunsun Nam, Ph.D., Professor of Biochemistry and Biophysics at UT Southwestern Medical Center, will receive the 2026 Edith and Peter O’Donnell Award in Biological Sciences from the Texas Academy of Medicine, Engineering, Science & Technology (TAMEST) for her research into how RNAs and proteins

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50 percent in patients with a history of liver cancer.